Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Guohao Lu"'
Autor:
Shixing Gu, Zhenyu Gong, Shuncai Liu, Guohao Lu, Yu Ling, Yanlin Wei, Ting Li, Ronghe Gu, Yongxian Rong, Junjun Li, Hongmian Li
Publikováno v:
Stem Cells International, Vol 2023 (2023)
Chronic refractory wounds (CRW) are one of the most serious clinical challenges for surgeons to address. Stromal vascular fraction gels (SVFG), including human adipose stem cells (hASCs), have excellent vascular regenerative and tissue repair propert
Externí odkaz:
https://doaj.org/article/0fcba60a5b914c12aeac6b793be29c1d
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Denosumab (DMAB), a human monoclonal antibody against the receptor activator of the nuclear factor-kappa B ligand, is used for the treatment for unresectable giant cell tumor of bone (GCTB). However, little is known about the molecular and functional
Externí odkaz:
https://doaj.org/article/6411740234b446b39853c80238feb97e
Autor:
Wei Zhao, Changye Zou, Guohao Lu, Zhuoxing Gao, Jiayan Yang, Zhenguo Liu, Li Wang, Jincan He, Yangyang He, Bing Lu
Supplementary Figure 1. Super-enhancers (SEs) in osteosarcoma cells. Related to Figure 1. Supplementary Figure 2. LIF promotes epithelial-mesenchymal transition (EMT) gene expression. Related to Figure 2. Supplementary Figure 3. GSK-J4 inhibits stem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1844ada275bfd540abfe3e5472be2e66
https://doi.org/10.1158/1541-7786.22512982.v1
https://doi.org/10.1158/1541-7786.22512982.v1
Autor:
Wei Zhao, Changye Zou, Guohao Lu, Zhuoxing Gao, Jiayan Yang, Zhenguo Liu, Li Wang, Jincan He, Yangyang He, Bing Lu
Osteosarcoma is an aggressive malignancy with poor prognosis. Super-enhancers (SE) have been highlighted as critical oncogenic elements required for maintaining the cancer cell characteristics. However, the regulatory role of SEs in osteosarcoma prop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ab567bd463eb16782c97900fe835223
https://doi.org/10.1158/1541-7786.c.6540403.v1
https://doi.org/10.1158/1541-7786.c.6540403.v1
Autor:
Li Xiangyu, Jiaming Yu, Changye Zou, Li Wang, Liying Wang, Wei Zhao, Guohao Lu, Congxiu Miao, Jun Wu
Publikováno v:
Biomaterials Science. 8:5888-5899
Anti-angiogenic tyrosine kinase inhibitors (TKIs) have been proved to be effective in prolonging progression-free survival in advanced osteosarcoma. However, osteosarcoma stem-like cells persist for a long time and ultimately cause disease recurrence
Autor:
Li Wang, Guohao Lu, Zhuoxing Gao, Jiayan Yang, Bing Lu, Zhenguo Liu, Jincan He, Changye Zou, Wei Zhao, Yangyang He
Publikováno v:
Molecular Cancer Research. 18:57-67
Osteosarcoma is an aggressive malignancy with poor prognosis. Super-enhancers (SE) have been highlighted as critical oncogenic elements required for maintaining the cancer cell characteristics. However, the regulatory role of SEs in osteosarcoma prop
Publikováno v:
Frontiers in Immunology; 9/12/2022, Vol. 12, p1-14, 14p
Autor:
Xiangyu, Li, Liying, Wang, Li, Wang, Jiaming, Yu, Guohao, Lu, Wei, Zhao, Congxiu, Miao, Changye, Zou, Jun, Wu
Publikováno v:
Biomaterials science. 8(21)
Anti-angiogenic tyrosine kinase inhibitors (TKIs) have been proved to be effective in prolonging progression-free survival in advanced osteosarcoma. However, osteosarcoma stem-like cells persist for a long time and ultimately cause disease recurrence
Autor:
Xinru You, Li Wang, Jun Wu, Changye Zou, Wei Zhao, Jiali Liu, Bing Lu, Guohao Lu, Minglin Ma, Tianqi Yi, Xiaojia Huang
Publikováno v:
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-13 (2020)
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-13 (2020)
The adaptation of osteosarcoma cells to therapeutic pressure impedes the efficacy of chemotherapy for osteosarcoma. However, the characteristics and cellular organization of therapy-resistant cells in osteosarcoma tumors remain elusive. Here, we util
Publikováno v:
Physica A: Statistical Mechanics and its Applications. 512:1009-1018
Due to the short mechanism of the commodity futures market, a dynamic weighted money flow model is proposed in this paper. The model proposed herein is based on the original money flow model but considers the impact of changes in both open interest a